NLRP3 and HIV infectious disease: Based on our previous research, HIV infection and associated metabolic disturbances may activate signaling pathways such as NLRP3 inflammasome and JNK, thereby interfering with insulin signaling (e.g., the PI3K/AKT pathway) and establishing a vicious cycle of chronic inflammation and insulin resistance (33–35).